MedTrace Logo

Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients

NCT01108757 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2017-10-18

Study results available
· View outcomes & findings →

Summary

The study will assess the risk of catheter associated urinary tract infection in women undergoing incontinence or reconstructive pelvic surgery. Women will be given an antibiotic or placebo at the time of catheter removal. The investigators hypothesize that prophylactic antibiotics will reduce the rate of infection.

Conditions

  • Catheter-Associated Urinary Tract Infection

Interventions

DRUG

Bactrim

Bactrim DS BID for 3 days

OTHER

Placebo

Corn starch capsules

Sponsors & Collaborators

  • American Urogynecologic Society

    collaborator OTHER

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Matthew D Barber, MD MHS · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01108757 on ClinicalTrials.gov